AAAAAA

   
Results: 1-8 |
Results: 8
MRI staging using gadodiamide for soft-tissue tumors of the head and neck region. Results from a phase II trial and a 5-year clinical follow-up
Authors: Ekholm, SE Bjork-Eriksson, T Western, A Nellstrom, H Jonsson, E Johansson, A Lonn, L Mercke, C Tollesson, PO
Citation: Se. Ekholm et al., MRI staging using gadodiamide for soft-tissue tumors of the head and neck region. Results from a phase II trial and a 5-year clinical follow-up, EUR J RAD, 39(3), 2001, pp. 168-175
UFT/leucovorin in advanced squamous cell carcinoma of the head and neck administered with radiotherapy
Authors: Mercke, C
Citation: C. Mercke, UFT/leucovorin in advanced squamous cell carcinoma of the head and neck administered with radiotherapy, ONCOLOGY-NY, 14(10), 2000, pp. 79-81
Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers
Authors: Bjork-Eriksson, T West, C Karlsson, E Mercke, C
Citation: T. Bjork-eriksson et al., Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers, INT J RAD O, 46(1), 2000, pp. 13-19
Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentretrial
Authors: Westman, G Bergman, B Albertsson, M Kadar, L Gustavsson, G Thaning, L Andersson, M Straumits, A Jeppson, B Linden, CJ Ewers, SB Andersson, H Mercke, C Hafstrom, L Birck, O Orgum, P
Citation: G. Westman et al., Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentretrial, EUR J CANC, 35(4), 1999, pp. 586-595
The immunohistochemical expression of DNA-PKCS and Ku (p70/p80) in head and neck cancers: Relationships with radiosensitivity
Authors: Bjork-Eriksson, T West, C Nilsson, A Magnusson, B Svensson, M Karlsson, E Slevin, N Lewensohn, R Mercke, C
Citation: T. Bjork-eriksson et al., The immunohistochemical expression of DNA-PKCS and Ku (p70/p80) in head and neck cancers: Relationships with radiosensitivity, INT J RAD O, 45(4), 1999, pp. 1005-1010
The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53expression and radiosensitivity for head and neck cancers
Authors: Bjork-Eriksson, T West, CML Cvetskovska, E Svensson, M Karlsson, E Magnusson, B Slevin, NJ Edstrom, S Mercke, C
Citation: T. Bjork-eriksson et al., The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53expression and radiosensitivity for head and neck cancers, BR J CANC, 80(9), 1999, pp. 1400-1404
Discrimination of human tumor radioresponsiveness using low-dose rate irradiation
Authors: Bjork-Eriksson, T West, C Karlsson, E Mercke, C
Citation: T. Bjork-eriksson et al., Discrimination of human tumor radioresponsiveness using low-dose rate irradiation, INT J RAD O, 42(5), 1998, pp. 1147-1153
Accelerated hyperfractionated radiotherapy combined with induction and concomitant chemotherapy for inoperable non-small-cell lung cancer - Impact oftotal treatment time
Authors: Nyman, J Bergman, B Mercke, C
Citation: J. Nyman et al., Accelerated hyperfractionated radiotherapy combined with induction and concomitant chemotherapy for inoperable non-small-cell lung cancer - Impact oftotal treatment time, ACTA ONCOL, 37(6), 1998, pp. 539-545
Risultati: 1-8 |